First Tracks Biotherapeutics TRAX
+136.8%vs Day 1Spinoff of AnaptysBio (ANAB) · Classic Spinoff · Spun Apr 20, 2026
Current Stats
Post-Spinoff Performance
| Spinoff date | April 20, 2026 · Nasdaq |
| Days since spinoff | 112 days |
| Day 1 price (close) | $18.60 |
| Post-spin low | $15.32 on Jun 3, 2026 · 44 days post-spin |
| Current price (Jul 31, 2026) | $44.04 |
| Return vs Day 1 | +136.8% |
| Return vs post-spin low | +187.5% |
| Parent since spinoff | +4.7% |
Price History
yfinance (auto-adjusted close + volume). As of Aug 10, 2026.
Post Spin Analysis
Compiled from tracked data as of the July 31, 2026 close.
The move
First Tracks Biotherapeutics separated from AnaptysBio (ANAB) on April 20, 2026 as a classic spinoff, listing on Nasdaq. It closed its first regular-way session at $18.60 and set a post-spin low of $15.32 on Jun 3, 2026, 44 days after the spin. It last traded at $44.04 (Jul 31, 2026), +136.8% against the Day-1 close and +187.5% off the low.
Against the parent
AnaptysBio has returned +4.7% over the same window. The SpinCo is ahead of its former parent by roughly 132 percentage points since separation.
What we graded it
Covered in a single report before separation. Current rating: SPECULATIVE.
⚠ Auto-generated profile — not editorially reviewed.
This summary is compiled automatically from our tracked report data. A reviewed in-depth profile is planned. For further detail ▸ read the May 31, 2026 report.